Add to My Stocks
$1.71 $0.2 (13.25%) SRRA stock closing price Oct 12, 2018 (Closing)
Prev Close* : $1.51
Market Cap:
Day Low: $1.54
52 Week Low: $1.48
Open: $1.54
Volume: -
Day High: $1.72
52 Week High: $4.09

Latest Stock Market News

Latest Articles

SIERRA ONCOLOGY News - From Partners

SRRA Stockcharts

View SRRA PE ratio, PS ratio stocks charts and compare with peers.
SRRA Chart
Note: Compare SIERRA ONCOLOGY stock price history with the index and industry peers.


PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio


(return on equity)

SIERRA ONCOLOGY Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

SRRA Industry Peers

Company Price Change (%)
Cytodyn (CYDY)0.540 (0%)
Juniper Pharma (JNP)11.50 (0%)
Steadymed (STDY)4.730 (0%)
Cti Biopharma (CTIC)1.940.03 (1.52%)
Juno Therapeutics (JUNO)86.960 (0%)
Abbvie (ABBV)90.690.01 (0.01%)
Epizyme (EPZM)9.340.09 (0.97%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Redhill Biopharma (RDHL)7.990.59 (7.97%)
MediWound (MDWD)60.38 (6.76%)
BioCryst Pharma (BCRX)7.010.38 (5.73%)
Zogenix (ZGNX)41.532.17 (5.51%)
Aerie Pharma (AERI)55.372.81 (5.35%)
Tesaro Inc (TSRO)40.61.95 (5.05%)
Endo International (ENDP)17.510.71 (4.23%)
Top gainers from Medical-Drugs industry
* As of Oct 12, 2018
CompanyPriceChange (%)
Corcept Therapeutics (CORT)12.240.68 (5.26%)
AVADEL PHARMA (AVDL)4.380.18 (3.95%)
ImmunoGen (IMGN)7.380.3 (3.91%)
Achaogen (AKAO)3.720.12 (3.13%)
MELINTA THERAPT (MLNT)3.730.12 (3.12%)
Aratana Therapeutics (PETX)5.280.17 (3.12%)
TherapeuticsMD (TXMD)5.420.17 (3.04%)
Top losers from Medical-Drugs industry
* As of Oct 12, 2018

SIERRA ONCOLOGY Stock News - Partner Headlines

SIERRA ONCOLOGY Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-42.01M--53.26M-23.87M-6.83M
Total Operating Expense42.61M035.82M22.57M4M
View SIERRA ONCOLOGY income statement
balance sheet20172016201520142013
Total Assets102.19M110.97M152.76M40.56M2.46M
Total Liabilities7.47M7.72M7.39M148.38M1.76M
Shareholders Equity94.72M103.24M145.37M-107.81M-
View SIERRA ONCOLOGY balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.34M-4.22M--
Net Cash from (used by) Operating Activities-36.16M--28.26M-21.78M-3.57M
Increase (Decrease) in Prop Plant And Equipment-0.09M--0.41M-0.18M-
View SIERRA ONCOLOGY cash flow statement

SIERRA ONCOLOGY Stock Message Board

SIERRA ONCOLOGY stock price ended the last trading day at $1.71. Stock price or share price can be used to find the total market value of a company. SIERRA ONCOLOGY market cap stands at $127.13M as of Oct 12, 2018. A value investor must look at the fundamentals of a stock, and perform SIERRA ONCOLOGY valuation, even though in the short-term, sentiment and current breaking news might affect SIERRA ONCOLOGY stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that SIERRA ONCOLOGY is worth a lot, it will most likely be reflected in an inflated SIERRA ONCOLOGY stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 467,177 SRRA shares were traded yesterday, and SIERRA ONCOLOGY stock chart shows that the SRRA stock quote hit a day high of $1.72 and day low of $1.54. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. SIERRA ONCOLOGY dividend per share was 0.00 during the last quarter. SIERRA ONCOLOGY stock price history, gives the entire historical data for SRRA stock.